NCT06717425: An ongoing trial by Pfizer
This trial is ongoing. It must report results 10 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06717425 |
|---|---|
| Title | A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING STUDY OF PF-07976016 TO ASSESS SAFETY AND EFFICACY IN ADULT PARTICIPANTS WITH OBESITY |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 9, 2024 |
| Completion date | Oct. 23, 2025 |
| Required reporting date | Oct. 23, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |